Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.
Publication
, Journal Article
Bory, C; Boulieu, R; Souillet, G; Chantin, C; Guibaud, P; Hershfield, MS
Published in: Adv Exp Med Biol
1991
Duke Scholars
Published In
Adv Exp Med Biol
DOI
ISSN
0065-2598
Publication Date
1991
Volume
309A
Start / End Page
173 / 176
Location
United States
Related Subject Headings
- Severe Combined Immunodeficiency
- Male
- Lymphocytes
- Infant
- Humans
- General & Internal Medicine
- Female
- Erythrocytes
- Child, Preschool
- Child
Citation
APA
Chicago
ICMJE
MLA
NLM
Bory, C., Boulieu, R., Souillet, G., Chantin, C., Guibaud, P., & Hershfield, M. S. (1991). Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool. Adv Exp Med Biol, 309A, 173–176. https://doi.org/10.1007/978-1-4899-2638-8_39
Bory, C., R. Boulieu, G. Souillet, C. Chantin, P. Guibaud, and M. S. Hershfield. “Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.” Adv Exp Med Biol 309A (1991): 173–76. https://doi.org/10.1007/978-1-4899-2638-8_39.
Bory C, Boulieu R, Souillet G, Chantin C, Guibaud P, Hershfield MS. Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool. Adv Exp Med Biol. 1991;309A:173–6.
Bory, C., et al. “Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.” Adv Exp Med Biol, vol. 309A, 1991, pp. 173–76. Pubmed, doi:10.1007/978-1-4899-2638-8_39.
Bory C, Boulieu R, Souillet G, Chantin C, Guibaud P, Hershfield MS. Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool. Adv Exp Med Biol. 1991;309A:173–176.
Published In
Adv Exp Med Biol
DOI
ISSN
0065-2598
Publication Date
1991
Volume
309A
Start / End Page
173 / 176
Location
United States
Related Subject Headings
- Severe Combined Immunodeficiency
- Male
- Lymphocytes
- Infant
- Humans
- General & Internal Medicine
- Female
- Erythrocytes
- Child, Preschool
- Child